Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-916
Closed -$66.3K – 298
2022
Q4
$66.3K Buy
916
+900
+5,625% +$64.5K 0.02% 154
2022
Q3
$1K Sell
16
-1,040
-98% -$66.4K ﹤0.01% 452
2022
Q2
$66K Sell
1,056
-440
-29% -$29.1K 0.02% 180
2022
Q1
$105K Hold
1,496
– – 0.03% 157
2021
Q4
$93K Hold
1,496
– – 0.02% 172
2021
Q3
$92K Hold
1,496
– – 0.03% 166
2021
Q2
$90K Hold
1,496
– – 0.03% 170
2021
Q1
$91K Buy
1,496
+1,481
+9,873% +$81.7K 0.03% 176
2020
Q4
$1K Hold
15
– – ﹤0.01% 348
2020
Q3
$1K Sell
15
-1
-6% -$38 ﹤0.01% 326
2020
Q2
$1K Buy
16
+1
+7% +$35 ﹤0.01% 393
2020
Q1
$0 Hold
15
– – ﹤0.01% 342
2019
Q4
$1K Buy
+15
New +$724 ﹤0.01% 308

Other funds holding MET

Leelyn Smith's MET Position: Q1 2023 in Review

Leelyn Smith sold out of MetLife (MET) in Q1 2023, closing a stake of 916 shares — an estimated $66.3K sold.

Leelyn Smith first reported a position in MET in Q4 2019 and held it in 13 quarters. The position peaked at $105K in Q1 2022. 1,213 funds tracked by Wall St. Rank hold MET as of Q1 2023.

  • Leelyn Smith reported no remaining MetLife position as of Q1 2023 after selling out during the quarter.
  • Leelyn Smith sold 916 MetLife shares in Q1 2023, an estimated $66.3K.
  • Leelyn Smith first reported a position in MetLife in Q4 2019 and held it in 13 quarters.
  • Leelyn Smith's MetLife position peaked at $105K in Q1 2022.
  • 1,213 funds tracked by Wall St. Rank held MetLife as of Q1 2023.

Based on Leelyn Smith's 13F filing for Q1 2023, filed 12 May 2023.